ResearcherZhejiang Provincial People's HospitalNo recent work listed
Dongsheng Huang
Matched on ORCID iD 0000-0003-2724-9618; OpenAlex author ID A5100599516. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 3)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 10
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper
Papers 6
- Bioinformatic analysis of FOXN3 expression and prognostic value in pancreatic cancer. Co-author DOI 10.3389/fonc.2022.1008100↗
- Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2021.771247↗
- Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer. Last author DOI 10.3389/fonc.2020.01220↗
- Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review. Last author DOI 10.3389/fphar.2020.579239↗
- Immunotherapy in pancreatic cancer: New hope or mission impossible? Co-author DOI 10.1016/j.canlet.2018.10.045↗
- Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway. Last author DOI 10.3892/or.2013.2385↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jiahong Jiang · 4 shared papers, 2019–2021 · strength 0.46
- Paper Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2021.771247↗
- Paper Conversion Therapy for Advanced Pancreatic Cancer: The Case Series and Literature Review. DOI 10.3389/fphar.2020.579239↗
- Paper Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Can… DOI 10.3389/fonc.2020.01220↗
- Liu Yang · 3 shared papers, 2019–2021 · strength 0.34
- Paper Genomic Landscape in Neoplasm-Like Stroma Reveals Distinct Prognostic Subtypes of Pancreatic Ductal Adenocarcinoma. DOI 10.3389/fonc.2021.771247↗
- Paper Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Can… DOI 10.3389/fonc.2020.01220↗
- Paper Immunotherapy in pancreatic cancer: New hope or mission impossible? DOI 10.1016/j.canlet.2018.10.045↗
- Zheling Chen · 2 shared papers, 2020–2021 · strength 0.24
- Xiaoge Hu · 2 shared papers, 2019–2020 · strength 0.22
- Jungang Zhang · 1 shared paper, 2022 · strength 0.15
- Yu Wei · 1 shared paper, 2022 · strength 0.15
- Mingxing Wang · 1 shared paper, 2020 · strength 0.11
- Yunyun Xu · 1 shared paper, 2020 · strength 0.11
- Yiping Mou · 1 shared paper, 2019 · strength 0.11
- Xiao‐dong Sun · 1 shared paper, 2013 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.